Metabolic Biomarker Testing Global Market Report 2025

Description

Metabolic biomarker testing involves analyzing specific molecules in biological samples, such as blood or urine, to evaluate metabolic processes and identify imbalances or dysfunctions. This testing is crucial for diagnosing metabolic disorders, monitoring health conditions, and developing personalized treatment strategies.

The primary types of metabolic biomarker testing include separation techniques, detection techniques, and other methods. Separation techniques utilize physical or chemical processes to isolate specific metabolites from biological samples based on properties such as size, charge, or affinity. This process aids in purifying and accurately identifying metabolic biomarkers. Indications for testing cover areas such as cancer, cardiovascular disorders, neurological disorders, inborn errors of metabolism, and more. Applications include drug assessment, nutrigenomics, toxicology testing, personalized medicine, and functional genomics. End users of metabolic biomarker testing include pharmaceutical and biotech companies, diagnostic tool companies, healthcare IT providers, and clinical laboratories.

The metabolic biomarker testing market research report is one of a series of new reports from the business research company that provides metabolic biomarker testing market statistics, including metabolic biomarker testing industry global market size, regional shares, competitors with an metabolic biomarker testing market share, detailed metabolic biomarker testing market segments, market trends and opportunities, and any further data you may need to thrive in the metabolic biomarker testing industry. This metabolic biomarker testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The metabolic biomarker testing market size has grown strongly in recent years. It will grow from $2.82 billion in 2024 to $3.06 billion in 2025 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of metabolic disorders, rising awareness about early disease detection, growing demand for personalized medicine, increasing prevalence of obesity and diabetes, and growing adoption of preventive healthcare measures.

The metabolic biomarker testing market size is expected to see strong growth in the next few years. It will grow to $4.2 billion in 2029 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on precision medicine, growth in personalized nutrition and wellness programs, increased funding for metabolic research, growing patient awareness and education, and rising prevalence of metabolic syndrome and related conditions. Major trends in the forecast period include advancements in high-throughput screening technologies, integration of artificial intelligence, integration of machine learning for biomarker analysis, advances in mobile health (mHealth) technologies, and expansion of telemedicine solutions for remote biomarker testing.

The increasing incidence of diabetes is expected to drive the growth of the metabolic biomarker testing market. Diabetes is a chronic condition marked by elevated blood glucose levels due to the body's inability to produce or properly use insulin. The rise in diabetes cases is influenced by poor dietary habits, particularly high consumption of processed foods and sugary drinks, along with sedentary lifestyles with minimal physical activity. Additionally, aging populations and family history of diabetes contribute to increased risk, indicating a genetic predisposition. Metabolic biomarker testing aids in diagnosing, monitoring, and managing metabolic diseases such as diabetes by providing detailed insights into metabolic functions and abnormalities at a molecular level. For example, in May 2024, the British Diabetic Association, a U.K.-based non-profit organization, reported that 4.3 million individuals in the UK are currently diagnosed with diabetes, with an increase of 148,951 cases in 2022 compared to 2021. Furthermore, over 2.4 million people in the UK are at high risk of developing type 2 diabetes. Thus, the rising incidence of diabetes is set to propel the growth of the metabolic biomarker testing market.

Major companies in the metabolic biomarker testing market are focusing on technological advancements, such as biowearables for self-monitoring, to enable users to continuously track and manage their nutritional and health indicators. These biowearables provide real-time, non-invasive monitoring of key metabolic markers such as glucose, supporting personalized health management and optimizing diet and athletic performance. For example, in January 2022, Abbott Laboratories, a US-based medical device company, introduced the Lingo biowearable. Designed to be worn on the upper arm for up to two weeks, it allows users to monitor glucose, ketone, and lactate levels, offering continuous insights into metabolic health. Utilizing technology from Abbott's FreeStyle Libre, the device aims to enhance general wellness and athletic performance rather than serving as a medical diagnostic tool. The initial launch was planned for Europe under the Lingo Keto brand, making it available directly to consumers without a prescription.

In June 2024, Lifesum AB, a Sweden-based provider of a healthy eating and wellness platform, acquired Lykon GmbH for an undisclosed amount. This acquisition is intended to integrate Lykon's biomarker testing into Lifesum's platform, enhancing the ability to offer personalized health insights, expanding wellness services, and bolstering Lifesum's position in the advanced wellness market. Lykon GmbH, based in Germany, specializes in personalized metabolic and nutritional testing.

Major companies operating in the metabolic biomarker testing market are Thermo Fisher Scientific Inc., Danaher Corporation, Agilent Technologies Inc., PerkinElmer Inc., bioMerieux S.A., LECO Corporation, Shimadzu Corporation, Waters Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, SCIEX, Promega Corporation, Cayman Chemical Company, Metabolon Inc., Biocrates Life Sciences AG, Human Metabolome Technologies Inc., KineMed Inc., Evosep Biosystems A/S, Creative Proteomics Inc., Lipotype GmbH, Metabolomic Diagnostics Ltd, Stemina Biomarker Discovery Inc., Chenomx Inc., GlycoPath Pty Ltd

North America was the largest region in the metabolic biomarker testing market in 2024. The regions covered in the metabolic biomarker testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the metabolic biomarker testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The metabolic biomarker testing market consists of revenues earned by entities by providing services such as laboratory testing, analysis of blood, urine, and other biological samples, and personalized health assessments. The market value includes the value of related goods sold by the service provider or included within the service offering. The metabolic biomarker testing market also includes sales of diagnostic kits, assay reagents, and testing equipment. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Metabolic Biomarker Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on metabolic biomarker testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for metabolic biomarker testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The metabolic biomarker testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:1) By Type: Separation Techniques; Detection Techniques; Other Types
2) By Indication: Cancer; Cardiovascular Disorders; Neurological Disorders; Inborn Errors Of Metabolism; Other Indications
3) By Application: Drug Assessment; Nutrigenomics; Toxicology Testing; Personalized Medicine; Functional Genomics; Other Applications
4) By End User: Pharma And Biotech Companies; Diagnostic Tool Companies; Healthcare Information Technology (IT); Clinical Laboratories
Subsegments:
1) By Separation Techniques: Chromatography; Capillary Electrophoresis; Mass Spectrometry (MS); Liquid-Liquid Extraction; Solid-Phase Extraction
2) By Detection Techniques: Enzyme-Linked Immunosorbent Assay (ELISA); Western Blotting; Fluorescence-Based Detection; Electrochemical Detection; Nuclear Magnetic Resonance (NMR); Immunoassays
3) By Other Types: Genetic Biomarker Testing; Protein Biomarker Testing; Metabolomics Profiling; Spectroscopy Techniques; Microarray Technology
Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Agilent Technologies Inc.; PerkinElmer Inc.; bioMerieux S.A.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Product Code: r33503

1. Executive Summary

2. Metabolic Biomarker Testing Market Characteristics

3. Metabolic Biomarker Testing Market Trends And Strategies

4. Metabolic Biomarker Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Metabolic Biomarker Testing Growth Analysis And Strategic Analysis Framework

5.1. Global Metabolic Biomarker Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Metabolic Biomarker Testing Market Growth Rate Analysis
5.4. Global Metabolic Biomarker Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Metabolic Biomarker Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Metabolic Biomarker Testing Total Addressable Market (TAM)

6. Metabolic Biomarker Testing Market Segmentation

6.1. Global Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Separation Techniques
Detection Techniques
Other Types
6.2. Global Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Cancer
Cardiovascular Diorders
Neurological Disorders
Inborn Errors Of Metabolism
Other Indications
6.3. Global Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Drug Assessment
Nutrigenomics
Toxicology Testing
Personalized Medicine
Functional Genomics
Other Applications
6.4. Global Metabolic Biomarker Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Pharma And Biotech Companies
Diagnostic Tool Companies
Healthcare Information Technology (IT)
Clinical Laboratories
6.5. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Separation Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chromatography
Capillary Electrophoresis
Mass Spectrometry (MS)
Liquid-Liquid Extraction
Solid-Phase Extraction
6.6. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Detection Techniques, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA)
Western Blotting
Fluorescence-Based Detection
Electrochemical Detection
Nuclear Magnetic Resonance (NMR)
Immunoassays
6.7. Global Metabolic Biomarker Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Genetic Biomarker Testing
Protein Biomarker Testing
Metabolomics Profiling
Spectroscopy Techniques
Microarray Technology

7. Metabolic Biomarker Testing Market Regional And Country Analysis

7.1. Global Metabolic Biomarker Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Metabolic Biomarker Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Metabolic Biomarker Testing Market

8.1. Asia-Pacific Metabolic Biomarker Testing Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Metabolic Biomarker Testing Market

9.1. China Metabolic Biomarker Testing Market Overview
9.2. China Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Metabolic Biomarker Testing Market

10.1. India Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Metabolic Biomarker Testing Market

11.1. Japan Metabolic Biomarker Testing Market Overview
11.2. Japan Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Metabolic Biomarker Testing Market

12.1. Australia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Metabolic Biomarker Testing Market

13.1. Indonesia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Metabolic Biomarker Testing Market

14.1. South Korea Metabolic Biomarker Testing Market Overview
14.2. South Korea Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Metabolic Biomarker Testing Market

15.1. Western Europe Metabolic Biomarker Testing Market Overview
15.2. Western Europe Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Metabolic Biomarker Testing Market

16.1. UK Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Metabolic Biomarker Testing Market

17.1. Germany Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Metabolic Biomarker Testing Market

18.1. France Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Metabolic Biomarker Testing Market

19.1. Italy Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Metabolic Biomarker Testing Market

20.1. Spain Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Metabolic Biomarker Testing Market

21.1. Eastern Europe Metabolic Biomarker Testing Market Overview
21.2. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Metabolic Biomarker Testing Market

22.1. Russia Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Metabolic Biomarker Testing Market

23.1. North America Metabolic Biomarker Testing Market Overview
23.2. North America Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Metabolic Biomarker Testing Market

24.1. USA Metabolic Biomarker Testing Market Overview
24.2. USA Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Metabolic Biomarker Testing Market

25.1. Canada Metabolic Biomarker Testing Market Overview
25.2. Canada Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Metabolic Biomarker Testing Market

26.1. South America Metabolic Biomarker Testing Market Overview
26.2. South America Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Metabolic Biomarker Testing Market

27.1. Brazil Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Metabolic Biomarker Testing Market

28.1. Middle East Metabolic Biomarker Testing Market Overview
28.2. Middle East Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Metabolic Biomarker Testing Market

29.1. Africa Metabolic Biomarker Testing Market Overview
29.2. Africa Metabolic Biomarker Testing Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Metabolic Biomarker Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Metabolic Biomarker Testing Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Metabolic Biomarker Testing Market Competitive Landscape And Company Profiles

30.1. Metabolic Biomarker Testing Market Competitive Landscape
30.2. Metabolic Biomarker Testing Market Company Profiles
- 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.2. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
- 30.2.3. Agilent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.4. PerkinElmer Inc. Overview, Products and Services, Strategy and Financial Analysis
- 30.2.5. bioMerieux S.A. Overview, Products and Services, Strategy and Financial Analysis

31. Metabolic Biomarker Testing Market Other Major And Innovative Companies

31.1. LECO Corporation
31.2. Shimadzu Corporation
31.3. Waters Corporation
31.4. Bio-Rad Laboratories Inc.
31.5. Bruker Corporation
31.6. SCIEX
31.7. Promega Corporation
31.8. Cayman Chemical Company
31.9. Metabolon Inc.
31.10. Biocrates Life Sciences AG
31.11. Human Metabolome Technologies Inc.
31.12. KineMed Inc.
31.13. Evosep Biosystems A/S
31.14. Creative Proteomics Inc.
31.15. Lipotype GmbH

32. Global Metabolic Biomarker Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Metabolic Biomarker Testing Market

34. Recent Developments In The Metabolic Biomarker Testing Market

35. Metabolic Biomarker Testing Market High Potential Countries, Segments and Strategies

35.1 Metabolic Biomarker Testing Market In 2029 - Countries Offering Most New Opportunities
35.2 Metabolic Biomarker Testing Market In 2029 - Segments Offering Most New Opportunities
35.3 Metabolic Biomarker Testing Market In 2029 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
250423_r33503_Metabolic_Biomarker_Testing_GMR_2025